CIK 0000921299 · Non-accelerated filer<br>Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770357827
- Phone
- 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-09 | Wettig Thane CEO | Grant or award · Stock Option (Right to Buy) | +1,300,000 | 1,300,000 | ||
| 2024-12-07 | Graham Juan CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,066 | $0.34 | $365 | 164,863 |
| 2024-12-06 | Graham Juan CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,446 | $0.34 | $495 | 165,929 |
| 2024-12-06 | Wettig Thane CEO | Shares withheld for taxes | −2,363 | $0.34 | $808 | 419,953 |
| 2024-12-06 | Chung Christine SVP, CHINA OPERATIONS | Shares withheld for taxes | −2,792 | $0.34 | $955 | 301,552 |
| 2024-09-07 | Graham Juan CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,065 | $0.39 | $415 | 167,375 |
| 2024-09-06 | Graham Juan CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −16,050 | $0.39 | $6K | 168,440 |
| 2024-09-06 | Wettig Thane CEO | Shares withheld for taxes | −2,363 | $0.39 | $922 | 422,316 |
| 2024-09-06 | Chung Christine SVP, CHINA OPERATIONS | Shares withheld for taxes | −17,395 | $0.39 | $7K | 304,344 |
| 2024-08-01 | Wettig Thane CEO | Shares withheld for taxes | −20,840 | $0.47 | $10K | 424,679 |
| 2024-06-22 | Wettig Thane CEO | Shares withheld for taxes | −782 | $1.13 | $884 | 445,519 |
| 2024-06-12 | Adib Deyaa Chief Medical Officer | Purchase | +22,123 | $1.17 | $26K | 82,123 |
| 2024-06-07 | Graham Juan CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,182 | $1.10 | $1K | 184,490 |
| 2024-06-06 | Graham Juan CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −17,797 | $1.19 | $21K | 185,672 |
| 2024-06-06 | Chung Christine SVP, CHINA OPERATIONS | Shares withheld for taxes | −19,289 | $1.19 | $23K | 321,739 |
| 2024-06-06 | Wettig Thane CEO | Shares withheld for taxes | −2,255 | $1.19 | $3K | 446,301 |
| 2024-06-05 | Schoeneck James A Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-06-05 | Lema Gerald Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-06-05 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-06-05 | EDWARDS JEFFREY L Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 |
Page 3 of 8 · 156 trades